WELLlife™ COVID-19 / Influenza A&B Antigen Test
WELLlife™ COVID-19 / Influenza A&B Antigen Test
The WELLlife™ COVID-19 / Influenza A&B Antigen Test is a rapid, easy-to-use immunochromatographic assay designed for the qualitative detection of COVID-19 and Influenza A & B antigens from a single sample. This dual-detection test enables quick and accurate differentiation between respiratory infections with similar symptoms, supporting timely diagnosis and appropriate care decisions. Engineered for precision and efficiency, WELLlife™ delivers reliable results within minutes, making it suitable for both clinical and point-of-care settings.
Key Features
Dual Detection Capability: Simultaneously identifies COVID-19 and Influenza A & B
Rapid Results: Provides clear and dependable results within minutes
High Accuracy: Designed to deliver consistent performance aligned with clinical standards
User-Friendly Design: Simple testing procedure for efficient use
Efficient Screening: Helps distinguish between infections with overlapping symptoms
Flexible Use: Suitable for professional and point-of-care environments
Applications in MAT Clinics
Clinical Diagnosis: Supports healthcare professionals in identifying respiratory infections quickly
Point-of-Care Testing: Ideal for clinics, urgent care centers, and healthcare facilities
Patient Management: Assists in making informed treatment and isolation decisions
Seasonal Screening: Useful during flu season for fast and accurate testing
Compliance & Safety
The WELLlife™ COVID-19 / Influenza A&B Antigen Test is manufactured in ISO-certified facilities under strict quality control standards. It complies with relevant FDA and CE regulatory guidelines for diagnostic testing, ensuring safety, reliability, and consistent performance for professional use.
Resources
Validate your login